Announcement on Subsidiary's Obtainment of Drug Registration Certificate for Compound Ipratropium Bromide Solution for Inhalation

About this update from Zhejiang Conba Pharmaceutical Co., Ltd. Class A

Announcement on Subsidiary's Obtainment of Drug Registration Certificate for Compound Ipratropium Bromide Solution for InhalationThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Zhejiang Conba Pharmaceutical Co., Ltd. Class A